Drug intelligence / Profile preview

4-({[(4-methylpiperazin-1-yl)amino]carbonothioyl}amino)benzenesulfonamide

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the benzenesulfonamide class. It is primarily known as an experimental inhibitor of carbonic anhydrase II, a zinc metalloenzyme involved in the reversible hydration of carbon dioxide. The compound acts as a sulfonamide-based inhibitor and has been structurally characterized in complex with human carbonic anhydrase II. There are no approved therapeutic indications or clinical trials for this molecule, and it remains at the experimental research stage[1][7][8]. Its primary use is as a tool compound in biochemical studies of enzyme inhibition.

Other names
3-(4-methylpiperazin-1-yl)-1-(4-sulfamoylphenyl)thiourea4-{[(4-methylpiperazin-1-yl)carbamothioyl]amino}benzenesulfonamide4-[3-(4-Methyl-piperazin-1-y)-thioureido]-benzenesulfonamideBenzenesulfonamide, 4-[[[(4-methyl-1-piperazinyl)amino]thioxomethyl]amino]
02

Targets

CA2 (Carbonic Anhydrase 2)

Beyond the preview

Go deeper on 4-({[(4-methylpiperazin-1-yl)amino]carbonothioyl}amino)benzenesulfonamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-({[(4-methylpiperazin-1-yl)amino]carbonothioyl}amino)benzenesulfonamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call